Haemonetics Corporation to Present at UBS Global Lifesciences Conference

BRAINTREE, Mass., Sept. 16 /PRNewswire-FirstCall/ -- Haemonetics Corporation (NYSE: HAE) announced today that Christopher Lindop, CFO & VP, Business Development, will present at the UBS Global Lifesciences Conference in New York on Monday, September 20, 2010 at 12:30 pm Eastern time.

The public may access Mr. Lindop’s presentation live via webcast at http://cc.talkpoint.com/ubsx001/092110a_lv/?entity=153_EKOSRY1. The webcast will be archived and available approximately one hour after the presentation ends at 1:00 pm Eastern time.

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, IT products, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.

SOURCE Haemonetics Corporation